查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1358101

鴉片類藥物市場：依藥物類型、依用途、依給藥給藥、依配銷通路、依地區

Opioid Drugs Market, by Drug Type, by Application, by Route of Administration, by Distribution Channel, and by Region
出版日期: | 出版商: Coherent Market Insights | 英文 203 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2023 年，全球鴉片類藥物市場價值將達到 450 億美元，預測期內（2023-2030 年）年複合成長率為 3.3%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 450億美元
實績資料 2018-2021 預測期 2023-2030
預測期年複合成長率 3.30% 2030年市場規模預測 565億美元
鴉片類藥物全球市場佔有率(%)（依藥物類別），2023 年
鴉片類藥物市場-IMG1

鴉片類藥物是作用於鴉片受體產生嗎啡樣作用的物質。出於醫療目的，主要用於麻醉等止痛。其他醫療用途包括控制腹瀉、鴉片類藥物使用疾患的替代療法、鴉片類藥物過量攝取逆轉和咳嗽抑制。嗎啡是最早的鴉片類藥物之一，於 1803 年開發出來。鴉片類藥物作用於中樞和周邊神經系統的鴉片受體以緩解疼痛。鴉片類藥物以口服錠劑、腸胃外溶液、貼片和錠劑的形式給藥。處方鴉片類藥物有許多不同類型，包括芬太尼、羥考酮、嗎啡、可待因、羥嗎啡酮和氫可酮，醫生開處方主要用於治療疼痛。

市場動態

主要市場參與者正在關注產品發布和核准等內部成長策略，預計這將在預測期內推動市場成長。此外，隨著全球人口老化的增加，鴉片類藥物的使用預計會增加。老年人患有更多合併症，心血管疾病、關節炎和癌症等慢性疾病的風險更高。因此，老年人患病的增加預計將推動市場成長。此外，癌症、關節炎引起的慢性疼痛、腰痛、纖維肌痛和術後疼痛等慢性疾病的患病不斷上升，預計也會在預測期內增加鴉片類藥物作為止痛藥的使用，預計將推動市場成長。例如，根據美國疾病管制與預防中心 (CDC) 2021 年 10 月發布的情況說明書，約四分之一的美國成年人 (23.7%)，即約 5850 萬人，被醫生診斷患有關節炎. ，預計到2045 年將達到7,800 萬人。

本研究的主要特點

  • 本報告對全球鴉片類藥物市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和復合年度（年複合成長率）。
  • 它還揭示了各個部門市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 它根據公司亮點、產品系列、主要亮點、財務實績和策略等參數，介紹了全球鴉片類藥物市場的主要企業。
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
  • 全球鴉片類藥物市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 透過分析全球鴉片類藥物市場時所使用的各種策略矩陣，促進相關人員的決策。

目錄

第1章 調查目的和假設

  • 這項研究的目的
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章 市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 市場機會
  • 影響分析
  • 近期產品發布
  • 流行病學
  • 合併、收購和合作
  • 法規場景
  • 主要進展
  • 贖回場景
  • PEST分析
  • 波特的分析

第4章 全球鴉片類藥物市場，新型冠狀病毒影響分析

  • 經濟影響
  • 新型冠狀病毒（COVID-19）的流行病學
  • 對需求和供給的影響

第5章 全球鴉片類藥物市場，依藥物類別，2018-2030

  • 生物鹼
  • 嗎啡
  • 可待因
  • 半合成鴉片類藥物
  • 羥考酮
  • 氫可酮
  • 氫嗎啡酮
  • 合成鴉片類藥物
  • 芬太尼
  • 阿芬太尼

第6章 全球鴉片類藥物市場，依用途，2018-2030

  • 緩解疼痛
  • 止咳藥
  • 抑制腹瀉

第7章 全球鴉片類藥物市場，依給藥途徑，2018-2030

  • 口服
  • 局部的
  • 胃腸外的
  • 其他（肌肉注射等）

第8章 全球鴉片類藥物市場，依配銷通路分類，2018-2030 年

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第9章 全球鴉片類藥物市場，依地區，2018-2030

  • 北美洲
  • 美國
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章 競爭形勢

  • 公司簡介
    • Teva Pharmaceutical Industries Ltd.
    • Johnson &Johnson
    • Endo International plc
    • Lupin Limited
    • Cadila Healthcare Limited
    • Purdue Pharma LP
    • AbbVie Inc.
    • Fresenius Kabi
    • Mallinckrodt Pharmaceuticals
    • Pfizer Inc.
    • Rhodes Pharmaceuticals LP
    • Sun Pharmaceutical Industries Limited
    • Nesher Pharmaceuticals（USA）LLC
    • Amneal Pharmaceuticals LLC
    • Trevena Inc.
    • Aurobindo Pharma Limited

第11章章節

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI1017

The global opioid drugs market is estimated to be valued at US$ 45.0 billion in 2023 and is expected to exhibit a CAGR of 3.3% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 45.0 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 3.30% 2030 Value Projection: US$ 56.5 Bn
Global Opioid Drugs Market Share (%), By Drug Class, 2023
Opioid Drugs Market - IMG1

Opioids are substances that act on opioid receptors to produce morphine-like effects. Medically, they are primarily used for pain relief, including anesthesia. Other medical uses include suppression of diarrhea, replacement therapy for opioid use disorder, reversing opioid overdose, and suppressing cough. One of the first opioid drugs, 'morphine', was developed in 1803. Opioid drugs act on the opioid receptors present in the central and peripheral nervous systems, thus providing relief from pain. Opioids are administered in the form of oral pills, parenteral liquids, patches, or lozenges. There are different types of prescription opioids available, such as fentanyl, oxycodone, morphine, codeine, oxymorphone, and hydrocodone, which are prescribed by physicians for mainly treating pain.

Market Dynamics

The key market players are focused on organic growth strategies such as product launches and approval, and this is expected to drive market growth for the forecast period. Moreover, the growing geriatric population globally is expected to increase the usage of opioids, as elderly people are at high risk of chronic diseases such as cardiovascular diseases, arthritis, and cancer due to the high comorbid conditions. Thus, the rising prevalence of old people is expected to drive market growth. In addition, the increasing prevalence of chronic diseases such as cancer, chronic pain due to arthritis, lower back pain, fibromyalgia, and postsurgical pain is also expected to increase the usage of opioids as pain relieving agents, which is expected to drive market growth for the forecast period. For instance, as per the factsheet published by the Center for Disease Control and Prevention (CDC) in October 2021, about 1 in 4 U.S. adults (23.7%), or about 58.5 million people, have doctor-diagnosed arthritis, and this is expected to reach 78 million by 2045.

Key features of the study:

  • This report provides an in-depth analysis of the global opioid drugs market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global opioid drugs market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Endo International plc, Lupin Limited, Cadila Healthcare Limited, Purdue Pharma L.P., AbbVie Inc., Fresenius Kabi, Mallinckrodt Pharmaceuticals, Pfizer Inc., Rhodes Pharmaceuticals L.P., Sun Pharmaceutical Industries Limited, Nesher Pharmaceuticals (USA) LLC, Amneal Pharmaceuticals LLC, Trevena Inc., and Aurobindo Pharma Limited
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global opioid drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global opioid drugs market.

Opioid Drugs Market Detailed Segmentation:

  • By Drug Class:
    • Alkaloids
    • Morphine
    • Codeine
    • Semisynthetic Opioids
    • Oxycodone
    • Hydrocodone
    • Hydromorphone
    • Synthetic Opioids
    • Fentanyl
    • Alfentanil
  • By Application:
    • Analgesia
    • Cough Suppression
    • Diarrhea Suppression
  • By Route of Administration:
    • Oral
    • Topical
    • Parenteral
    • Others (Intramuscular, etc.)
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Teva Pharmaceutical Industries Ltd.
    • Johnson & Johnson
    • Endo International plc
    • Lupin Limited
    • Cadila Healthcare Limited
    • Purdue Pharma L.P.
    • AbbVie Inc.
    • Fresenius Kabi
    • Mallinckrodt Pharmaceuticals
    • Pfizer Inc.
    • Rhodes Pharmaceuticals L.P.
    • Sun Pharmaceutical Industries Limited
    • Nesher Pharmaceuticals (USA) LLC
    • Amneal Pharmaceuticals LLC
    • Trevena Inc.
    • Aurobindo Pharma Limited

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Class
    • Market Snippet, By Application
    • Market Snippet, By Route of Administration
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • Reimbursement Scenario
  • PEST Analysis
  • PORTER'S Analysis

4. Global Opioid Drugs Market-COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Opioid Drugs Market, By Drug Class, 2018- 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Alkaloids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Morphine
  • codeine
  • Semisynthetic Opioids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Oxycodone
  • Hydrocodone
  • Hydromorphone
  • Synthetic Opioids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Fentanyl
  • Alfentanil

6. Global Opioid Drugs Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Analgesia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Cough Suppression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Diarrhea Suppression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends

7. Global Opioid Drugs Market, By Route of Administration, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Parenteral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Others (Intramuscular, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends

8. Global Opioid Drugs Market, By Distribution Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

9. Global Opioid Drugs Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Company Profiles
    • Teva Pharmaceutical Industries Ltd.*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Johnson & Johnson
    • Endo International plc
    • Lupin Limited
    • Cadila Healthcare Limited
    • Purdue Pharma L.P.
    • AbbVie Inc.
    • Fresenius Kabi
    • Mallinckrodt Pharmaceuticals
    • Pfizer Inc.
    • Rhodes Pharmaceuticals L.P.
    • Sun Pharmaceutical Industries Limited
    • Nesher Pharmaceuticals (USA) LLC
    • Amneal Pharmaceuticals LLC
    • Trevena Inc.
    • Aurobindo Pharma Limited

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact